Problems of medicines for the elderly highlighted at UK conference

10 September 2006

Researchers have found that more than a quarter (28%) of the UK's elderly population may be missing out on essential prescribed medical treatments, either because they simply are not taking their medicines or not doing so effectively, according to a study presented at the British Pharmaceutical Conference, the annual meeting of the Royal Pharmaceutical Society of Great Britain, held earlier this month in Manchester.

It is a known fact amongst health researchers that such medication-related problems are common in the elderly, especially in those living alone. This study, carried out by pharmacists at the Robert Gordon University in Aberdeen, Scotland, aimed to find out exactly why elderly people do not take their medicines. A 58-item questionnaire was mailed to residents living in 24 sheltered housing complexes in Aberdeen. Respondents were aged between 78 and 86 years old. The research found that:

- 28% of people said that they did not always take their medicines;

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight